Squarepoint Ops LLC Amylyx Pharmaceuticals, Inc. Transaction History
Squarepoint Ops LLC
- $93.7 Billion
- Q2 2025
A detailed history of Squarepoint Ops LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 40,643 shares of AMLX stock, worth $500,315. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,643
Previous 75,849
46.42%
Holding current value
$500,315
Previous $268,000
2.99%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AMLX
# of Institutions
152Shares Held
76.1MCall Options Held
212KPut Options Held
40.6K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.8MShares$108 Million0.1% of portfolio
-
Perceptive Advisors LLC New York, NY7.9MShares$97.3 Million2.22% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$73.2 Million7.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.27MShares$64.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.54MShares$55.8 Million0.07% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $721M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...